Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Oct 18, 2013

NEW YORK (GenomeWeb News) – The Genome Analysis Centre in Norwich, UK, has named Mario Caccamo to be its new director.

Caccamo joined TGAC in 2009 as head of bioinformatics, and he became deputy director of science in 2012 and interim director early this year. He has 15 years of experience in algorithms research, including working at the Wellcome Trust Sanger Institute and the European Bioinformatics Institute. While at TGAC, Caccamo's research has focused on wheat and barley genomics research, and he has contributed to the development of new algorithmic approaches to dealing with large biological data sets.

The Children's Hospital of Philadelphia has named Toumy Guettouche to be senior scientist and director of sequencing within CHOP's Center for Applied Genomics. He reports to Hakon Hakonarson, who heads the center.

Guettouche joins CHOP from the University of Miami, Miller School of Medicine, where he was most recently the director of research and development in the CLIA laboratory of the University's Clinical and Translational Genetics. His previous roles at the University of Miami include director of genome technology assessment and implementation and director of the oncogenomics core facility.

Atossa Genetics said this week that Gregory Weaver has joined its board of directors and has been named to serve on Atossa's audit committee.

Weaver currently is CFO, senior VP, treasurer, and corporate secretary at Fibrocell Science, and before that he was CFO at Celsion, Poniard Pharmaceuticals, Sirna Therapeutics, Nastech Pharmaceuticals, and other drug companies.

The Translational Genomics Research Institute has named former US Surgeon General Richard Carmona to serve on its National Advisory Committee on rare childhood disorders. TGen announced the appointment this week in connection with the ribbon-cutting of a new clinical center in its Center for Rare Childhood Disorders.

Carmona will serve on NAC's Scientific-Medical Advisory Sub-Committee, which is focused on helping geneticists and healthcare professionals work together to incorporate genomic technologies into clinical care. Carmona, who currently is president of the Canyon Ranch Institute, was appointed US surgeon general in 2002 by President George W. Bush.

Oxford Cancer Biomarkers said this week that it has appointed David Oxlade to be company chairman.

Oxlade oversaw the launch of Cellmark Diagnostics while he was at ICI Pharmaceuticals, and he spent 14 years with Boehringer Mannheim. He formerly was CEO of the drug discovery and development company Xenova Group, and before that he was president of the medical diagnostics company Syva Company. He also currently is chairman of TranScrip Partners LLP, base4innovation, and Kirkstall.

Denator has appointed Karsten Fjärstedt to be VP of global sales and marketing. In the role, he will be responsible for all sales and marketing activities.

Fjärstedt joins Denator from GE Healthcare Life Sciences, where he has held senior executive management positions for over a decade. He also has more than 24 years of experience working in the biotech and pharmaceutical industries.

The Australian firm Genetic Technologies said this week that company CEO Alison Mew will step aside from her day-to-day responsibilities for a three-month period for personal reasons. During her absence, CFO Tom Howitt will assume the role of acting CEO, and he will be assisted by Chairman Mal Brandon and by external advisors.

The College of American Pathologists swore in Gene Herbek as its new president on Oct. 12 at a ceremony in Orlando, Fla. Herbek, an active member of the national pathology organization for more than two decades, is CAP's 33rd president. He is medical director of two Omaha, Neb.-based labs, the Methodist Women's Hospital laboratory and the Pathology Center at Methodist Hospital.

Herbek takes over the presidency from Stanley Robboy.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.